# The Bridging Antiplatelet Therapy With Cangrelor 2 Study

> **NCT07225842** · PHASE4 · RECRUITING · sponsor: **University of Florida** · enrollment: 50 (estimated)

## Conditions studied

- Coronary Arterial Disease (CAD)

## Interventions

- **DRUG:** Cangrelor

## Key facts

- **NCT ID:** NCT07225842
- **Lead sponsor:** University of Florida
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-02-18
- **Primary completion:** 2027-09
- **Final completion:** 2027-11
- **Target enrollment:** 50 (ESTIMATED)
- **Last updated:** 2026-05-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07225842

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07225842, "The Bridging Antiplatelet Therapy With Cangrelor 2 Study". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07225842. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*